Department of Health

All Corrs from the NSAC, relating to the consideration of SMA (Spinal Muscular Atrophy) in the bloodspot testing programme, to the following: Novartis, including but not limited to Novartis Gene Therapies, SMA Ireland, The European Alliance for Newborn Screening in SMA, SMA Europe.